Researchers have shown that two lab-developed and nasally-delivered peptides helped slow the spread of alpha-synuclein in mice. 'If these results can be replicated in patients, it would be a remarkable advance in the treatment of devastating neurological disorders,' says the lead author.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210921171801.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210921171801.htm
Nasal drugs show promise for slowing Parkinson’s disease progression in lab study
Reviewed by cmakigo
on
September 22, 2021
Rating:
No comments:
Post a Comment